![\"\"](\"https:\/\/investinnavarra.com\/wp-content\/uploads\/2024\/05\/140524SA_NAGENDATA1.jpg\")
<\/p>\nNAGENdata follows the guidelines of the European Health Data Space (EHDS) and the Integrated Strategy for Personalised Medicine of the Government of Navarra, which promote the reuse of genomic data to improve healthcare, research and economic development. Since 2016, Navarrabiomed has executed the NAGEN Programme, funded by GEMA challenge calls, implementing genomic sequencing in the Navarra Health Service. This programme includes six strategic projects that have collected nearly 3,000 genomes and exomes from patients for various purposes, from the diagnosis of rare diseases to reproductive medicine.<\/p>\n
<\/p>\n
These initiatives have established in Navarra the infrastructures and methodologies necessary for the advanced use of genomic medicine, providing clinical evidence of its multiple applications in the health system. As a result, Navarra has established itself as a European benchmark in personalised medicine. Dr. Virginia Garc\u00eda Solaesa, principal investigator of NAGENdata, highlights the importance of this data collection, which is now available to the scientific community and the public, guaranteeing privacy and security, to develop and optimise new therapies and drugs.<\/p>\n
On the other hand, NAGENdata is part of the call for grants for Strategic R&D Projects in personalised medicine of the Government of Navarra 2023, under the GEMA VII challenge, for which it has received a contribution of 830,813 euros from the Department of Industry and Ecological and Digital Business Transition of the Government of Navarra.<\/p>\n